Maintenance of elevated versus physiological iron indices in non-anaemic patients with chronic kidney disease: A randomized controlled trial

Nephrology Dialysis Transplantation

Volumn 25, Issue 3, 2010, Pages 920-926

  McMahon, Lawrence P ^a   Kent, Annette B ^a   Kerr, Peter G ^b   Healy, Helen ^c   Irish, Ashley B ^d   Cooper, Bruce ^e   Kark, Adrian ^c   Roger, Simon D ^f  

^a Eastern Health ^*  (Australia)

^b MONASH MEDICAL CENTRE   (Australia)

^c ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^d ROYAL PERTH HOSPITAL   (Australia)

^e ROYAL NORTH SHORE HOSPITAL   (Australia)

^f GOSFORD HOSPITAL   (Australia)

Author keywords

Chronic kidney disease; Haemoglobin; Iron sucrose; Oral iron; Randomized controlled trial

Indexed keywords

CREATININE; FERRIC HYDROXIDE SUCROSE; FERRITIN; FERROUS SULFATE; HEMOGLOBIN; TRANSFERRIN;

ADULT; ADVERSE OUTCOME; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC PATIENT; FEMALE; FERRITIN BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HEMOGLOBIN SYNTHESIS; HUMAN; IRON THERAPY; KIDNEY FUNCTION; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OPEN STUDY; PARAMETER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TRANSFERRIN BLOOD LEVEL; TREATMENT DURATION; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

ADMINISTRATION, ORAL; AGED; ANEMIA; CHRONIC DISEASE; FEMALE; FERRIC COMPOUNDS; FERRITINS; FERROUS COMPOUNDS; HEMATINICS; HEMOGLOBINS; HUMANS; INJECTIONS, INTRAVENOUS; IRON; KIDNEY DISEASES; MALE; MIDDLE AGED; RENAL DIALYSIS; SEVERITY OF ILLNESS INDEX;

EID: 77649212913     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfp584     Document Type: Article

References (15)

1. Macdougall IC, Tucker B, Thompson J, et al. A randomized controlled study of iron supplementation in patients treated with eryth-ropoietin. Kidney Int 1996; 50: 1694-1699
2. Besarab A, Amin N, Ahsan M, et al. Optimization of epoetin therapy with intravenous iron therapy in hemodialysis patients. JASN 2000; 11: 530-538
3. Chang CH, Chang CC, Chiang SS. Reduction in erythropoietin doses by the use of chronic intravenous iron supplementation in iron-replete hemodialysis patients. Clin Nephrol 2002; 57: 136-141
4. Charytan C, Qunibi W, Bailie GR. Comparison of intravenous iron sucrose to oral iron in the treatment of anemic patients with chronic kidney disease not on dialysis. Nephron Clin Pract 2005; 100: c55-c62
5. Stoves J, Inglis H, Newstead CG. A randomized study of oral vs intravenous iron supplementation in patients with progressive renal insufficiency treated with erythropoietin. Nephrol Dial Transplant 2001; 16: 967-974
6. Levey AS, Coresh J, Greene T, et al. Using standardized serum cre-atinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006; 145: 247-254
7. Roger SD, McMahon LP, Hawley C, et al. The role of epoetin alfa in chronic kidney disease: effects on left ventricular mass and renal function. Results of a prospective randomized trial. J Am Soc Nephrol 2004; 15: 148-156
8. Pollock C, McMahon L. Caring for Australians with Renal Impairment (CARI). The CARI guidelines. Biochemical and haematolo-gical targets guidelines. Haemoglobin. Nephrology 2005; 10: S108-S115
9. Jenkins K. A review of the updated European Best Practice Guidelines for the management of anaemia in patients with chronic renal failure. EDTNA-ERCA J 2005; 31: 156-159
10. NKF KDOQI clinical practice guideline and clinical practice recommendations for anemia in chronic kidney disease, 2007 update of hemoglobin target. Am J KidneyDis 2007 September Supplement (available on-line at: www.kdoqi.org)
11. Van Wyck DB, Roppolo M, Martinez CO, et al. A randomized, controlled trial comparing IV iron sucrose to oral iron in anemic patients with nondialysis-dependent CKD. Kidney Int 2005; 68: 2846-2856
12. Silverberg DS, Blum M, Agbaria Z, et al. The effect of IV iron alone or in combination with low-dose erythropoietin in the rapid correction of anemia of chronic renal failure in the predialysis period. Clin Nephrol 2001; 3: 212-219
13. Silverberg DS, Iaina A, Peer G, et al. Intravenous iron supplementation for the treatment of the anemia of moderate to severe chronic renal failure patients not receiving dialysis. Am J Kidney Dis 1996; 27: 234-238
14. Spinowitz BS, Kausz AT, Baptista J, et al. Ferumoxytol for treating iron deficiency anemia in CKD. J Am Soc Nephrol 2008; 19: 1599-1605
15. Mircescu G, Garneata L, Capusa C, et al. Intravenous iron supplementation for the treatment of anaemia in pre-dialyzed chronic renal failure patients. Nephrol Dial Transplant 2006; 21: 120-124